![Cory Ellspermann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cory Ellspermann
Director of Finance/CFO at
INMUNE BIO INC.
Net worth: - $ as of 30/06/2026
Profile
Cory Ellspermann is Senior Manager-Accounting at Artivest Holdings, Inc. since 2017.
Mr. Ellspermann is Chief Financial Officer at INmune Bio, Inc. starting in 2025.
Formerly, Mr. Ellspermann was Chief Accounting Officer at iDirect Private Markets Fund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INMUNE BIO, INC. -.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Cory Ellspermann active positions
| Companies | Position | Start |
|---|---|---|
| INMUNE BIO INC. | Director of Finance/CFO | 07/08/2025 |
Artivest Holdings, Inc.
 Artivest Holdings, Inc. Financial ConglomeratesFinance Provides investment services | Comptroller/Controller/Auditor | 01/01/2017 |
Former positions of Cory Ellspermann
| Companies | Position | End |
|---|---|---|
| ALTEGRIS KKR COMMITMENTS FUND | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
iDirect Private Markets Fund
 iDirect Private Markets Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Artivest Holdings, Inc.
Artivest Holdings, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
INmune Bio, Inc.
 INmune Bio, Inc. BiotechnologyHealth Technology Develops therapies that harness the patient's immune system to treat cancer | Health Technology |
- Stock Market
- Insiders
- Cory Ellspermann
